Takeda Pharmaceutical Co Ltd represents a focus on values and corporate philosophy that prioritize patient-centricity, integrity, and dedication to improving people's lives. Takeda is committed to delivering innovative and high-quality medicines, aiming to contribute to the health of patients worldwide. With a legacy spanning over 239 years, Takeda upholds a core mission to strive towards better health and a sustainable future. Their dedication to ethical practices, collaborative partnerships, and continuous innovation reinforces Takeda Pharmaceutical Co Ltd's position as a leading global pharmaceutical company.

Takeda Pharmaceutical Co Ltd is primarily present in various countries and regions worldwide. As a leading global pharmaceutical company, Takeda operates in multiple key markets, including Japan, the United States, Europe, and emerging markets in Asia, Latin America, and Africa. With a strong international presence, Takeda continues to expand its reach to bring innovative medicines and healthcare solutions to patients across the globe.

Takeda Pharmaceutical Co Ltd has achieved numerous significant milestones throughout its history. One key accomplishment was its establishment in 1781, making it one of the oldest pharmaceutical companies in Japan. Takeda has continued to innovate and excel in the healthcare industry, expanding its global presence and becoming the largest pharmaceutical company in Asia. It has made groundbreaking advancements in various therapeutic areas, such as gastroenterology, oncology, and neuroscience. Takeda's acquisition of Shire in 2019 further solidified its position as a leading global biopharmaceutical company. These achievements highlight Takeda Pharmaceutical Co Ltd's commitment to improving lives through its innovative medicines and therapies.

Takeda Pharmaceutical Co Ltd is a renowned pharmaceutical company with a rich history and strong global presence. Founded in 1781 in Osaka, Japan, Takeda has grown to become one of the largest pharmaceutical companies in the world. Over the years, Takeda has focused on research and development, manufacturing, and marketing of a wide range of pharmaceutical products. With a commitment to improving the health of people worldwide, they have expanded their operations to over 80 countries. Takeda's success can be attributed to its dedication to innovation, high-quality products, and a focus on patient-centered healthcare solutions. Today, Takeda remains at the forefront of the industry, striving to address unmet medical needs and improve patients' lives globally.

The main competitors of Takeda Pharmaceutical Co Ltd in the market include multinational pharmaceutical companies such as Johnson & Johnson, Pfizer Inc., and Novartis AG. These companies are prominent players in the global pharmaceutical industry, with a diverse range of healthcare products and a significant market presence. Takeda Pharmaceutical Co Ltd faces competition from these established competitors in various therapeutic areas, including oncology, gastroenterology, and rare diseases. The company strives to maintain its competitive edge by leveraging its research and development capabilities, innovative product portfolio, and strategic collaborations, allowing it to compete effectively in the dynamic pharmaceutical market.

Takeda Pharmaceutical Co Ltd is primarily active in the pharmaceutical industry.

Takeda Pharmaceutical Co Ltd. operates under a research-based pharmaceutical business model. As a leading global biopharmaceutical company, Takeda focuses on discovering, developing, and distributing innovative medicines and healthcare solutions. The company is committed to improving the health and well-being of people worldwide through its strong portfolio of prescription drugs and therapies. Takeda's business model emphasizes leveraging its expertise in areas such as oncology, gastroenterology, neuroscience, and rare diseases to deliver life-changing treatments and therapies. With a dedication to innovation and collaboration, Takeda remains at the forefront of advancing healthcare and improving patient outcomes.

مُعامل القيمة السوقية إلى الأرباح لـ Takeda Pharmaceutical Co هو ٤٤٫١٩.

مُعامِل القيمة إلى المبيعات Takeda Pharmaceutical Co هو ١٫٤٩.

نقاط جودة AlleAktien لـ Takeda Pharmaceutical Co هي 4/10.

Takeda Pharmaceutical Co الإيرادات هي ٤٫٢٦ السيرة الذاتية. JPY.

صافي الربح Takeda Pharmaceutical Co هو ١٤٤٫٠٧ مليارات JPY.

Takeda Pharmaceutical Co Ltd is a Japanese pharmaceutical company founded in 1781. It is headquartered in Osaka and currently employs over 49,000 people worldwide. The company operates in over 70 countries and offers a wide range of innovative medicines. Takeda focuses on the fields of internal medicine, oncology, gastroenterology, and neurology.

يوزع Takeda Pharmaceutical Co أرباحًا قدرها ١٨٠٫٠٠ JPY من خلال 2 عمليات توزيع موزعة على مدار السنة.

Takeda Pharmaceutical Co يوزع أرباحًا 2 مرة في السنة.

الرمز الدولي للأوراق المالية الخاص بـTakeda Pharmaceutical Co هو JP3463000004.

رمز WKN لـ Takeda Pharmaceutical Co هو 853849.

الرمز المُختصر لـ Takeda Pharmaceutical Co هو 4502.T.

خلال آخر 12 شهراً، دفعت Takeda Pharmaceutical Co توزيعات أرباح بقيمة ١٩٢٫٠٠ JPY . وهذا يعادل عائد توزيعات أرباح يقارب ٤٫٧٢ %. ومن المتوقع أن تدفع Takeda Pharmaceutical Co خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ١٨٥٫٢٣ JPY.

نسبة توزيعات الأرباح الحالية لـ Takeda Pharmaceutical Co هي ٤٫٧٢ %.

Takeda Pharmaceutical Co يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر أكتوبر, أبريل, أكتوبر, أبريل.

Takeda Pharmaceutical Co دفعت توزيعات الأرباح كل عام خلال الـ23 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ١٨٥٫٢٣ JPY. وهذا يعادل عائد توزيعات أرباح قدره ٤٫٥٥ %.

Takeda Pharmaceutical Co يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ٩٨ JPY من Takeda Pharmaceutical Co المُعلن عنها في ١‏/١٢‏/٢٠٢٤، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ٢٧‏/٩‏/٢٠٢٤.

تم توزيع آخر دفعة من الأرباح بتاريخ ١‏/١٢‏/٢٠٢٤.

في العام 2023، وزعت Takeda Pharmaceutical Co ١٨٤ JPY كأرباح أسهم.

يتم توزيع أرباح Takeda Pharmaceutical Co بالعملة JPY.